Literature DB >> 12087036

Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients.

John A Kiayias, Eugenia D Vlachou, Eleni Theodosopoulou, Elli Lakka-Papadodima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12087036     DOI： 10.2337/diacare.25.7.1251

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].

Authors:  Edelmiro Menéndez Torre; Francisco Javier Lafita Tejedor; Sara Artola Menéndez; Jesús Millán Núñez-Cortés; Angeles Alonso García; Manuel Puig Domingo; José Ramón García Solans; Fernando Alvarez Guisasola; Javier García Alegría; Javier Mediavilla Bravo; Carlos Miranda Fernández-Santos; Ramón Romero González
Journal:  Aten Primaria       Date:  2011-03-05       Impact factor: 1.137

Review 2.  Current therapeutic options in type 2 diabetes mellitus: a practical approach.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2003-07

Review 3.  Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.

Authors:  André J Scheen
Journal:  Drug Saf       Date:  2005-07       Impact factor: 5.606

Review 4.  Insulin therapy for type 2 diabetes.

Authors:  Afshin Sasali; Jack L Leahy
Journal:  Curr Diab Rep       Date:  2003-10       Impact factor: 4.810

5.  Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats.

Authors:  Ravi Prakash Rao; Ansima Singh; Arun K Jain; Bhartu Parsharthi Srinivasan
Journal:  J Biomed Res       Date:  2011-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.